General Tirzepatide lowers heart attack and cardiovascular event risk in adults with type 2 diabetesBy Healthcare Propulsion StaffAugust 10, 20260 Real-world data suggest tirzepatide may reduce major cardiovascular events beyond standard diabetes care, with the strongest signals seen for myocardial…
